<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1548">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 07, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02253732</url>
  </required_header>
  <id_info>
    <org_study_id>UEE-SAS</org_study_id>
    <nct_id>NCT02253732</nct_id>
  </id_info>
  <brief_title>Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism &amp; Cognitive Function: Role for Myokines &amp; miRNAs</brief_title>
  <acronym>Brain-Muscle</acronym>
  <official_title>Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism &amp; Cognitive Function: Role for Myokines &amp; miRNAs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Slovak Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Bratislava</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Slovak Academy of Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine specific changes in muscle secretory profile
      (myokines, miRNA) in association with neurodegenerative disease progression and metabolic
      dysfunction. Next the investigators would like to determine the shift in the muscle secretory
      activity induced by regular exercise intervention, which the investigators think could be
      translated into the beneficial changes in clinical phenotypes, determined by neuroimaging,
      cognitive function tests and metabolic phenotyping.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard Operating Procedures for patient recruitment, data collection, data management, data
      analysis routinely used in University Hospital Bratislava and in Institute of Experimental
      Endocrinology Slovak Academy of Sciences will be employed.

      Statistical analysis will be employed to address the primary and secondary objectives, as
      specified in the study protocol.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>muscle microRNAs and myokines</measure>
    <time_frame>up to 24 months</time_frame>
    <description>We will determine muscle bioactive secretory products (myokines &amp; miRNAs) that are regulated by acute bout of exercise in patients with neurodegenerative disease as well as in sedentary age, gender and BMI matched controls in association with their metabolic phenotype.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>whole body energy metabolism</measure>
    <time_frame>up to 24 months</time_frame>
    <description>changes in whole body energy metabolism will be determined with indirect calorimetry. &amp; oral glucose tolerance test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cognitive function</measure>
    <time_frame>up to 24 months</time_frame>
    <description>exercise related changes in cognitive &amp; motoric functions will be determined with the aid of questionaires, and proton (1H)-magnetic resonance spectroscopy - brain imaging and spectroscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>motoric function</measure>
    <time_frame>up to 30 months</time_frame>
    <description>Proton (1H)-magnetic resonance spectroscopy - brain imaging and spectroscopy, motoric - balance testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle functional tests</measure>
    <time_frame>up to 30 months</time_frame>
    <description>Dynamometry will be used to determine maximal voluntary contraction force and the rate of force development, and Phosphorus (31P)-magnetic resonance spectroscopy to measure muscle metabolism in vivo.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Alzheimer Disease</condition>
  <condition>Parkinson Disease</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>all participants will be subjected to 3 months supervised exercise intervention programme</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>3 months exercise intervention program</intervention_name>
    <description>3 months exercise intervention program which is given 3-times per week, 60 min session duration, 65-75% repetition maximum or heart rate maximum, combined strength &amp; aerobic exercises</description>
    <arm_group_label>exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent.

          2. Diagnosed with Parkinson disease

          3. Diagnosed with mild cognitive impairment (MCI) or Alzheimer disease (AD)

        Exclusion Criteria:

          1. Serious systemic cardiovascular, hepatic, renal disease, cancer.

          2. Lack of compliance.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Valkovic, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Bratislava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stanislav Sutovsky, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Bratislava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Ukropcova, MD, PhD</last_name>
    <phone>+421-2-5477-2800</phone>
    <phone_ext>254</phone_ext>
    <email>barbara.ukropcova@savba.sk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jozef Ukropec, PhD</last_name>
    <phone>+421-2-5477-2800</phone>
    <phone_ext>205</phone_ext>
    <email>jozef.ukropec@savba.sk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univeristy Hospital in Bratislava</name>
      <address>
        <city>Bratislava</city>
        <zip>81369</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislav Sutovsky, MD, PhD</last_name>
      <email>nilusuto@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Stanislav Sutovsky, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Valkovic, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inst. Exp. Endocrinology Slovak Acad Sci</name>
      <address>
        <city>Bratislava</city>
        <zip>83306</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Ukropcova, MD, PhD</last_name>
      <phone>+421-2-5477-2800</phone>
      <phone_ext>254</phone_ext>
      <email>Barbara.Ukropcova@savba.sk</email>
    </contact>
    <investigator>
      <last_name>Jozef Ukropec, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Ukropcova, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miroslav Vlcek, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timea Kurdiova, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miroslav Balaz, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michaela Jakubova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrik Krumpolec, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Vallova, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denisa Maderova, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- Old date names will be dropped in a few months (sometime in 2018)                        -->
  <lastchanged_date>September 28, 2014</lastchanged_date>
  <firstreceived_date>September 25, 2014</firstreceived_date>
  <!-- New date names                                                                           -->
  <study_first_submitted>September 25, 2014</study_first_submitted>
  <study_first_submitted_qc>September 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2014</study_first_posted>
  <last_update_submitted>September 28, 2014</last_update_submitted>
  <last_update_submitted_qc>September 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2014</last_update_posted>
  <!-- End of dates                                                                             -->
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Slovak Academy of Sciences</investigator_affiliation>
    <investigator_full_name>Jozef Ukropec</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>MicroRNAs</keyword>
  <keyword>exercise</keyword>
  <keyword>skeletal muscle</keyword>
  <keyword>metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

